You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 4, 2026

Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative
Published on: August 21, 2021
Malcolm Macleod1, Swapna Mohan2
1Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
This review examines the challenges of ensuring reliable and repeatable results in animal-based experiments. It explores how study design, statistical interpretation, and reporting practices influence the development of new medical treatments. The authors also propose strategies like pre-registration and improved education to enhance scientific rigor.
Area of Science:
Background:
Scientific communities currently face significant challenges regarding the reliability of findings derived from living models. That uncertainty drove a critical examination of how laboratory practices influence the validity of biomedical discoveries. Prior research has shown that inconsistent outcomes often stem from flaws in experimental structure or reporting. No prior work had resolved how these specific failures impede the translation of animal data into human therapies. This gap motivated a comprehensive assessment of current standards within the field. Investigators have long recognized that the path from bench to bedside requires robust evidence. However, the prevalence of non-replicable data remains a persistent hurdle for modern medicine. Addressing these systemic issues is necessary to maintain public trust and scientific progress.
Purpose Of The Study:
The aim of this review is to evaluate the key factors influencing the reliability of animal-based research. This study addresses the persistent problem of non-replicable findings that hinder medical progress. The authors seek to define essential concepts that guide researchers toward more robust experimental practices. They examine how current methods in design and reporting contribute to the broader crisis of scientific reproducibility. The motivation for this work stems from the need to improve the translation of laboratory discoveries into effective human therapeutics. By analyzing systemic weaknesses, the researchers intend to provide a clear path for enhancing scientific standards. This investigation highlights the importance of understanding the epistemology behind animal experiments. Ultimately, the work serves to inform the community on strategies for fostering a more rigorous research environment.
Main Methods:
The review approach involved a systematic synthesis of existing literature regarding experimental standards. Investigators analyzed evidence from various published studies to identify common flaws in laboratory conduct. The authors evaluated how different design choices influence the validity of reported outcomes. This process included a critical assessment of statistical interpretation methods used in animal models. The team examined data from multiple systematic reviews to map the landscape of current reporting practices. They also explored the role of pre-registration in reducing bias within the scientific pipeline. The methodology focused on identifying actionable strategies to enhance the quality of future investigations. This comprehensive survey provided a clear framework for understanding the current state of scientific rigor.
Main Results:
Key findings from the literature suggest that design weaknesses significantly undermine the translation of animal data into human medical treatments. The authors report that inconsistent reporting practices are a primary driver of non-replicable results across the field. Evidence indicates that failed replication attempts often provide meaningful knowledge that can refine future experimental hypotheses. The review shows that current statistical practices frequently misrepresent the general truth of observed phenomena. Systematic reviews demonstrate that these structural failures are widespread in contemporary biomedical publications. The authors note that the community response to these challenges has been varied but increasingly focused on transparency. Data suggest that pre-registered protocols can effectively reduce the prevalence of selective reporting. Finally, the literature confirms that improved education is a key factor in enhancing overall research performance.
Conclusions:
The authors propose that adopting pre-registered protocols will strengthen the integrity of future investigations. They suggest that open access to raw data facilitates greater transparency across the global research community. Synthesis and implications indicate that failed replication attempts provide valuable insights rather than just negative outcomes. The researchers emphasize that formal training programs are vital for enhancing the quality of experimental execution. They argue that standardized reporting practices help mitigate common biases found in published literature. The review highlights that systemic changes in how scientists document their work are required to improve reliability. The authors conclude that a shift toward open science practices supports more accurate medical advancements. Finally, they maintain that these collective efforts will ultimately bolster the credibility of animal-based studies.
The authors propose that reproducibility issues arise from flawed experimental design, inadequate statistical interpretation, and poor reporting practices. These factors hinder the translation of animal findings into human therapeutics, whereas rigorous pre-registration and open data sharing are suggested to mitigate these systemic weaknesses.
The researchers highlight the importance of pre-registered study protocols, open publication, and open data. These tools are contrasted with traditional, less transparent reporting methods, which often lack the documentation necessary for independent verification of experimental results.
The authors suggest that education is necessary to improve research performance. This is contrasted with current practices where a lack of formal training in experimental design and statistical analysis contributes to the prevalence of non-replicable findings.
The authors utilize systematic reviews and experimental studies as the primary data types. These sources are used to evaluate the impact of design weaknesses on the development of new treatments, providing evidence that contrasts with anecdotal observations of research failures.
The researchers examine the phenomenon of statistical significance and its relationship to general truth. They propose that understanding this concept is vital, as it differs from the mere observation of p-values in isolated experiments.
The authors imply that the biomedical research community must adopt a culture of transparency. They suggest that this shift is required to address the current crisis of confidence, contrasting it with the status quo of opaque reporting standards.